Tag archive for ‘Anti-emetic Drug Formulation’
Ilan Shavit On Wednesday, October 9th, 2013

Redhill Biopharma Seeks Meeting With FDA For Extended Release Anti-emetic Drug Formulation

– RedHill Biopharma Ltd. (Redhill) reported positive pharmacokinetic (PK) clinical studies for their planned new drug application (NDA) for their RHB-102 extended release Anti-Emetic product. RedHill More...

Wordpress site Developed by Fixing WordPress Problems